Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ADMA – Adma Biologics Inc

ADMA Biologics Inc
ADMA
$18.16
Name : ADMA Biologics Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $4,335,409,152.00
EPSttm : 0.84
finviz dynamic chart for ADMA
ADMA Biologics Inc
$18.16
1.30%
$0.24

Float Short %

5.99

Margin Of Safety %

51

Put/Call OI Ratio

0.42

EPS Next Q Diff

0.06

EPS Last/This Y

-0.24

EPS This/Next Y

0.34

Price

18.15

Target Price

32.33

Analyst Recom

1.5

Performance Q

-10.45

Relative Volume

1.39

Beta

0.45

Ticker: ADMA




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02ADMA20.440.550.6989667
2025-06-03ADMA20.470.560.2988448
2025-06-04ADMA20.330.563.8988501
2025-06-05ADMA19.940.530.8786966
2025-06-06ADMA20.610.560.1288796
2025-06-09ADMA20.860.560.2889002
2025-06-10ADMA20.850.571.3689150
2025-06-11ADMA21.830.580.8189987
2025-06-12ADMA21.60.560.3286329
2025-06-13ADMA20.810.560.2885969
2025-06-16ADMA20.40.550.2486630
2025-06-17ADMA18.890.551.0986922
2025-06-18ADMA18.140.531.8488087
2025-06-20ADMA17.750.490.4586107
2025-06-23ADMA17.830.420.0761064
2025-06-24ADMA17.840.420.2361001
2025-06-25ADMA17.590.420.4961997
2025-06-26ADMA18.40.420.1663119
2025-06-27ADMA18.150.420.0663347
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02ADMA20.437.7- 0.60
2025-06-03ADMA20.467.7- 0.60
2025-06-04ADMA20.327.7- 0.60
2025-06-05ADMA19.947.7- 0.60
2025-06-06ADMA20.597.7- 0.61
2025-06-09ADMA20.877.7- 0.61
2025-06-10ADMA20.857.7- 0.61
2025-06-11ADMA21.847.7- 0.61
2025-06-12ADMA21.607.7- 0.61
2025-06-13ADMA20.817.7- 0.61
2025-06-16ADMA20.407.7- 0.61
2025-06-17ADMA18.917.7- 0.61
2025-06-18ADMA18.137.7- 0.61
2025-06-20ADMA17.747.7- 0.61
2025-06-23ADMA17.887.7- 0.61
2025-06-24ADMA17.847.7- 0.61
2025-06-25ADMA17.597.7- 0.61
2025-06-26ADMA18.407.7- 0.61
2025-06-27ADMA18.157.7- 0.61
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02ADMA-0.86-0.025.79
2025-06-03ADMA-0.86-0.025.79
2025-06-04ADMA-0.86-0.025.79
2025-06-05ADMA-0.86-0.025.79
2025-06-06ADMA-0.86-0.025.79
2025-06-09ADMA-0.860.205.79
2025-06-11ADMA-0.970.206.21
2025-06-12ADMA-1.210.206.21
2025-06-13ADMA-1.210.206.21
2025-06-16ADMA-1.210.226.21
2025-06-17ADMA-5.970.226.21
2025-06-18ADMA-5.970.226.21
2025-06-19ADMA-5.970.226.21
2025-06-20ADMA-6.190.226.21
2025-06-24ADMA-6.260.206.21
2025-06-25ADMA-6.260.206.21
2025-06-26ADMA-6.260.205.99
2025-06-27ADMA-6.260.205.99
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

0.11

Avg. EPS Est. Current Quarter

0.14

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

-6.26

Institutional Transactions

0.2

Beta

0.45

Average Sales Estimate Current Quarter

122

Average Sales Estimate Next Quarter

128

Fair Value

27.39

Quality Score

99

Growth Score

76

Sentiment Score

63

Actual DrawDown %

29.3

Max Drawdown 5-Year %

-70.9

Target Price

32.33

P/E

21.51

Forward P/E

19.32

PEG

0.55

P/S

9.44

P/B

11.6

P/Free Cash Flow

47.83

EPS

0.84

Average EPS Est. Cur. Y​

0.61

EPS Next Y. (Est.)

0.95

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

45.01

Relative Volume

1.39

Return on Equity vs Sector %

31.5

Return on Equity vs Industry %

49.3

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

ADMA Biologics Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 685
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
stock quote shares ADMA – Adma Biologics Inc Stock Price stock today
news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADMA – Adma Biologics Inc yahoo finance google finance
stock history ADMA – Adma Biologics Inc invest stock market
stock prices ADMA premarket after hours
ticker ADMA fair value insiders trading